Misonix Inc Revenue Growth Rates (MSON), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Misonix Inc   (NASDAQ: MSON)
 

MSON's Revenue Growth by Quarter and Year

Misonix Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MSON Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter June 19.69
3rd Quarter March 18.35
2nd Quarter December 18.26
1st Quarter September 17.74
FY 74.04

MSONs Annual Revenue
Misonix Inc 's Revenue in the fiscal year 2021 $ 74.02 millions
Misonix Inc 's Revenue in the fiscal year 2020 $ 62.48 millions
Misonix Inc 's Revenue in the fiscal year 2019 $ 38.85 millions
Misonix Inc 's Revenue in the fiscal year 2018 $ 36.68 millions
Misonix Inc 's Revenue in the fiscal year 2017 $ 27.27 millions




MSON Revenue fourth quarter 2021 Y/Y Growth Comment
Misonix Inc achieved in the fourth quarter 2021, above Company average Revenue rise of 43.58% year on year, to $ 19.69 millions.

Looking into fourth quarter 2021 results within Laboratory Analytical Instruments industry 14 other companies have achieved higher Revenue growth. While Misonix Inc ' s Revenue jump of 43.58% ranks overall at the positon no. 1498 in the fourth quarter 2021.


MSON Revenue ( Y/Y Growth %) 2021
 2020 2019 2018
4th Quarter June 43.58 % 40.62 % 12.85 % 9.51 %
3rd Quarter March 2.51 % 87.24 % -23.15 % 73.26 %
2nd Quarter December -7.4 % 93.71 % 22.36 % 37.98 %
1st Quarter September 59.1 % 19.12 % 28.57 % 17.99 %
FY   18.49 % 60.82 % 5.92 % -

Financial Statements
Misonix Inc 's fourth quarter 2021 Revenue $ 19.69 millions MSON's Income Statement
Misonix Inc 's fourth quarter 2020 Revenue $ 13.71 millions Quarterly MSON's Income Statement


MSON Revenue (Quarter on Quarter Growth %)

 2021
 2020 2019 2018
4th Quarter June 7.28 % -23.41 % 1.99 % -30.55 %
3rd Quarter March 0.49 % -9.23 % -6.09 % 49.52 %
2nd Quarter December 2.93 % 76.86 % 8.76 % 14.29 %
1st Quarter September 29.39 % 14.36 % 8.33 % -7.73 %
FY (Year on Year)   18.49 % 60.82 % 5.92 % -


Back to MSON Growth rate Comparisons >> Back to MSON Growth rate Comparisons >>


Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #15
Healthcare Sector #316
Overall #1498

Revenue Y/Y Growth Statistics
High Average Low
93.8 % 23.45 % -32.71 %
(Dec 31 2019)   (Sep 30 2013)
Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #15
Healthcare Sector #316
Overall #1498
Revenue Y/Y Growth Statistics
High Average Low
93.8 % 23.45 % -32.71 %
(Dec 31 2019)   (Sep 30 2013)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Misonix Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
76.94 % 3.42 % -100 %
(Dec 31 2019)  


MSON's IV. Quarter Q/Q Revenue Comment
Misonix Inc achieved in the IV. Quarter 2021 above company average sequential Revenue increase of 7.28%, to $ 19.69 millions, from $18.35 millions in the third quarter.
MSON is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Laboratory Analytical Instruments industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Misonix Inc 's Revenue growth quarter on quarter, overall rank is 1930.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #18
Healthcare Sector #335
Overall #1930
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #18
Healthcare Sector #335
Overall #1930
Revenue Q/Q Growth Statistics
High Average Low
76.94 % 3.42 % -100 %
(Dec 31 2019)  


MSON's IV. Quarter Q/Q Revenue Comment
Misonix Inc achieved in the IV. Quarter 2021 above company average sequential Revenue increase of 7.28%, to $ 19.69 millions, from $18.35 millions in the third quarter.
MSON is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Laboratory Analytical Instruments industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Misonix Inc 's Revenue growth quarter on quarter, overall rank is 1930.


Misonix Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2021)		 12 Months Ending
(Mar 31 2021)		 12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Sep 30 2020)		 12 Months Ending
(Jun 30 2020)
Cumulative Revenue 12 Months Ending $ 74.02 $ 68.05 $ 67.61 $ 69.07 $ 62.48
Y / Y Revenue Growth (TTM) 18.47 % 16.28 % 34.73 % 69.99 % 60.84 %
Year on Year Revenue Growth Overall Ranking # 407 # 847 # 32 # 70 # 285
Seqeuential Revenue Change (TTM) 8.78 % 0.66 % -2.12 % 10.55 % 6.76 %
Seq. Revenue Growth (TTM) Overall Ranking # 2078 # 2201 # 2487 # 132 # 513


Cumulative Revenue growth Comment
Although Misonix Inc 's Annual Revenue growth year on year were below company's average 25.53% , Revenue announced in the Jun 30 2021 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 18.47% year on year, from 16.28% in Mar 31 2021.

In the Healthcare sector 117 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 407, from total ranking in previous quarter at 847.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 18
Healthcare Sector # 118
Overall # 407

Revenue TTM Y/Y Growth Statistics
High Average Low
69.99 %
 25.53 %
2.87 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 330
S&P 500 # 2078
Cumulative Revenue growth Comment
Although Misonix Inc 's Annual Revenue growth year on year were below company's average 25.53% , Revenue announced in the Jun 30 2021 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 18.47% year on year, from 16.28% in Mar 31 2021.

In the Healthcare sector 117 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 407, from total ranking in previous quarter at 847.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 18
Healthcare Sector # 118
Overall # 407

Revenue TTM Y/Y Growth Statistics
High Average Low
69.99 %
25.53 %
2.87 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 330
S&P 500 # 2078




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MSON's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Jun 30 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2021
Henry Schein Inc 76.16%$ 76.159 millions
Penumbra Inc75.30%$ 75.302 millions
Silk Road Medical Inc 75.27%$ 75.275 millions
Atricure Inc 74.84%$ 74.838 millions
Caremax Inc 74.14%$ 74.138 millions
Alcon inc 73.81%$ 73.806 millions
Zevra Therapeutics Inc 73.51%$ 73.509 millions
Talkspace Inc 73.31%$ 73.312 millions
Bioadaptives Inc 73.19%$ 73.187 millions
Intuitive Surgical Inc 71.81%$ 71.811 millions
Veru Inc 71.05%$ 71.052 millions
Agilon Health Inc 69.95%$ 69.948 millions
Stereotaxis Inc 69.33%$ 69.329 millions
Atrium Therapeutics Inc 69.18%$ 69.176 millions
Hims and Hers Health Inc 69.04%$ 69.040 millions
Electrocore Inc 68.60%$ 68.598 millions
Globus Medical Inc 68.56%$ 68.555 millions
Asensus Surgical Inc 68.24%$ 68.244 millions
Arrowhead Pharmaceuticals Inc 67.63%$ 67.634 millions
Viatris Inc 67.61%$ 67.611 millions
Jrsis Health Care Corp67.33%$ 67.332 millions
Therapeutic Solutions International Inc 67.21%$ 67.206 millions
Cardiovascular Systems Inc 66.85%$ 66.848 millions
Seaspine Holdings Corporation66.02%$ 66.018 millions
Orthofix Medical Inc 65.99%$ 65.986 millions
Neuropace Inc 65.31%$ 65.314 millions
Zimmer Biomet Holdings Inc 65.31%$ 65.313 millions
Twist Bioscience Corporation65.12%$ 65.125 millions
Oak Street Health Inc 64.71%$ 64.706 millions
Natera Inc 64.25%$ 64.245 millions


About Misonix Inc Revenue Growth Rates (MSON), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.